ARTICLE Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy

Abstract

Cyclin-dependent kinases (CDKs) mediate cell cycle progression, regulating transition from G1 to S phase and G2 to M phase. CDK activity is tightly controlled throughout the cell cycle by posttran-scriptional modifications as well as the expression of cyclins and CDK inhibitors. There are four proliferative CDKs: CDK1, which predominantly regulates the transition from G2 to M phase, and CDK2/4/6, which regulate the transition from G1 to S phase (1,2). Recent work has shown that there is considerable redun-dancy among the CDKs that regulate the transition from the G1 to S phase, and many proliferating cells can use any of thes

Similar works

Full text

thumbnail-image
oai:CiteSeerX.psu:10.1.1.905.9143Last time updated on 11/1/2017

This paper was published in CiteSeerX.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.